Research programme: neuroinflammation therapeutics - EicOsis
Latest Information Update: 08 Feb 2024
At a glance
- Originator EicOsis
- Class Amides; Anti-inflammatories; Benzene derivatives; Piperidines; Small molecules
- Mechanism of Action Epoxide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Inflammation
Most Recent Events
- 17 Jan 2024 Early research in Inflammation in USA (PO), prior to January 2024 (EicOsis pipeline, January 2024)